Toshimi Takamura
About Toshimi Takamura
Toshimi Takamura serves as the Director of Clinical Operations at Day One Biopharmaceuticals, where he has worked since 2021. He has extensive experience in clinical research and operations, having held positions at notable institutions such as UCSF, The Ohio State University, OncoSec, and Iovance Biotherapeutics.
Current Role at Day One Biopharmaceuticals
Toshimi Takamura serves as the Director of Clinical Operations at Day One Biopharmaceuticals. In this role, she is responsible for overseeing clinical operations, ensuring that clinical trials are designed and executed effectively. She has been with the company since 2021 and has contributed to various aspects of clinical trial management.
Previous Experience at UCSF Helen Diller Family Comprehensive Cancer Center
Before joining Day One Biopharmaceuticals, Toshimi Takamura worked as a Clinical Research Coordinator in Melanoma and Cutaneous Oncology at UCSF Helen Diller Family Comprehensive Cancer Center. Her tenure lasted for one year, from 2012 to 2013, in the San Francisco Bay Area. During this time, she gained valuable experience in clinical research and patient management.
Professional Background at OncoSec
Toshimi Takamura held the position of Program Manager at OncoSec from 2013 to 2017 in the Greater San Diego Area. In this role, she managed various programs related to cancer research and clinical trials, contributing to the advancement of oncology treatments.
Education and Academic Background
Toshimi Takamura earned two degrees from The Ohio State University. She completed her Bachelor of Arts (B.A.) in Spanish Language and Literature and her Bachelor of Science (B.S.) in Biochemistry and Chemistry, both between 2008 and 2012. This educational foundation has supported her career in clinical research and operations.
Experience at Iovance Biotherapeutics, Inc.
Toshimi Takamura served as the Director of Clinical Operations at Iovance Biotherapeutics, Inc. from 2017 to 2021 in the Greater San Diego Area. In this position, she was responsible for overseeing clinical operations and ensuring the successful execution of clinical trials.